Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis
Bladder Cancer · 2026-03 · 12 (2)
DOI: 10.1177/23523735261455396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder Cancer, online erschienen am 28.05.2026. Verfasst von Aidan Boyne und 10 weiteren Autor:innen. Beteiligte Einrichtung: Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Urothelial bladder cancer exhibits marked molecular and clinical heterogeneity. While genomic and transcriptomic profiling of muscle-invasive bladder cancer (MIBC) has revealed recurrent alterations with therapeutic and prognostic relevance, limited access to molecular testing constrains clinical use. Computed tomography (CT), routinely performed for staging and surveillance, may serve as a noninvasive adjunct for tumor biology. Radiomics, the quantitative extraction of imaging features, offers a means to associate imaging phenotypes with molecular characteristics.
Methods
Genomic data for The Cancer Genome Atlas were integrated with CT images from the Cancer Imaging Archive for 89 patients with biopsy-proven MIBC. An in-house radiomics pipeline extracted 488 texture metrics characterizing the brightness distribution, pixel relationships, and spatial patterns of segmented tumors. Three classifiers - Random Forest, Extreme Gradient Boosting, and Elastic Net - were trained to predict DNA mutations, tumor mutational burden (TMB), and mRNA expression. Model performance was evaluated using 10-fold cross-validation.
Results
Among 15 recurrent mutations, EP300, FGFR3, and ARID1A were predicted most reliably (AUCs = 0.77, 0.76, 0.75). Models identified high-TMB tumors (AUC = 0.61), poor-prognosis transcriptomic signatures (AUC = 0.73, 0.65), expression of key cell cycle (CKDKN1A, AUC = 0.78) and apoptotic (CASP3, AUC = 0.71) genes, and discriminated the luminal infiltrated molecular subtype from other variants (AUC = 0.69).
Conclusion
Our study demonstrates that CT-derived radiomics features can capture biologically and clinically relevant information in muscle-invasive bladder cancer. These findings support the potential utility of radiomics as a noninvasive, scalable adjunct to genomic profiling in MIBC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
- Radiomics Lab, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- Alfred E Mann Dept of Biomedical Engineering, USC Viterbi School of Engineering, Los Angeles, CA, USA.
- Institute of Urology, University of Southern California, Los Angeles, CA, USA.
- Department of Radiology, Los Angeles General Medical Center, Los Angeles, CA, USA.
ORCID-Profile: Aidan Boyne
Zitieren
APA
Boyne, A., Anderson, R. C., Liu, D., Varghese, B., Lei, X., Hwang, D., King, K., Dani, K., Cen, S., Duddalwar, V., & Lerner, S. P. (2026). Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis. Bladder Cancer, 12(2). https://doi.org/10.1177/23523735261455396
Vancouver
Boyne A, Anderson RC, Liu D, Varghese B, Lei X, Hwang D, et al. Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis. Bladder Cancer. 2026;12(2). doi:10.1177/23523735261455396
BibTeX
@article{Boyne2026,
author = {Boyne, Aidan and Anderson, Redmond-Craig and Liu, Derek and Varghese, Bino and Lei, Xiaomeng and Hwang, Darryl and King, Kevin and Dani, Komal and Cen, Steven and Duddalwar, Vinay and Lerner, Seth P},
title = {Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis},
journal = {Bladder Cancer},
year = {2026},
volume = {12},
number = {2},
doi = {10.1177/23523735261455396}
}
EUVIMED